Indications and uses
to temporarily relieve symptoms commonly associated with arthritis and muscle pain, such as: • pain • inflammation • stiffness • swelling
to temporarily relieve symptoms commonly associated with arthritis and muscle pain, such as: • pain • inflammation • stiffness • swelling
Dispense Rhumatol directly into mouth, or add recommended dosage into 8-12 oz. of purified (non-chlorinated) water and drink. Safe for ages 2 and up.
• do not use if tamper seal is broken • store in a cool, dry place • product must not come in contact with metal • do not store next to electrical devices or appliances
Actaea spicata HPUS
Aesculus hippocastanum HPUS
Arnica montana HPUS
Bellis perennis HPUS
Bryonia HPUS
Calcarea carbonica HPUS
Calcarea fluorica HPUS
Causticum HPUS
Cimicifuga racemosa HPUS
Formicum acidum HPUS
Hypericum perforatum HPUS
Ledum paulstre HPUS
Lithium carbonicum HPUS
Magnesia phosphorica HPUS
Phosphorus HPUS
Phytolacca decandra HPUS
Pulsatilla HPUS
Rhododendron chrysanthum HPUS
Rhus toxicodendron HPUS
Ruta graveolens HPUS
Salicylicum acidum HPUS
Sepia HPUS
Zincum metallicum HPUS
Each ingredient contains equal volumes of 10X, 30X and LM1 potencies. The letters “HPUS” indicate that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of the United States.
Product indications are based on Homeopathic Materia Medica. Product indicatiosn are based on Homeopathic Materia Medica.
Actaea spicata HPUS.........................................Pain
Aesculus hippocastanum HPUS.................Weakness
Arnica montana HPUS................................Soreness
Bellis perennis HPUS............Rheumatism symptoms
Bryonia HPUS.............................................Stiffness
Calcarea carbonica HPUS.............Rheumatoid pains
Calcarea fluorica HPUS................................Burning
Causticum HPUS...................................Tearing pain
Cimicifuga racemosa HPUS…...............Restless limbs
Formicum acidum HPUS...........Nodes around joints
Hypericum perforatum HPUS....................Cramping
Ledum paulstre HPUS..................................Swelling
Lithium carbonicum HPUS....Rheumatism symptoms
Magnesia phosphorica HPUS........................Spasms
Phosphorus HPUS..........Paralysis in fingers and toes
Phytolacca decandra HPUS.........................Stiffness
Pulsatilla HPUS........................................Numbness
Rhododendron chrysanthum HPUS......Pain in joints
Rhus toxicodendron HPUS...............Pain in tendons
Ruta graveolens HPUS.............................Weakness
Salicylicum acidum HPUS............................Swelling
Sepia HPUS...........................Stiffness in extremities
Zincum metallicum HPUS..........................Twitching
to temporarily relieve symptoms commonly associated with arthritis and muscle pain, such as:
• pain
• inflammation
• stiffness
• swelling
• you are taking any other medications
• you have a medical condition
use only as directed.
symptoms persist or worsen.
ask a health professional before use.
Keep out of the reach of children.
Dispense Rhumatol directly into mouth, or add recommended dosage into 8-12 oz. of purified (non-chlorinated) water and drink. Safe for ages 2 and up.
30-50 lbs 1/2 mL
(13.6-22.6 kg) twice per day
50+ lbs 1 mL
(22.6+ kg) twice per day
External Use: If needed, apply to affected areas 2 - 6 times daily until symptoms improve.
• do not use if tamper seal is broken
• store in a cool, dry place
• product must not come in contact with metal
• do not store next to electrical devices or appliances
citric acid, potassium sorbate, purified ionized mineral water.
You can email us at
info@hellolife.net or call us toll-free at
1.800.875.0850 Monday through Friday, 9am-5pm ET
Mftd for: HelloLife, Inc.
4460 44th St. SE, Ste C-600
Grand Rapids, MI 49512
FDA Pharmaceutical Establishment
#1053442, #3009727070
www.rhumatol.com
NDC 49726-004-02
Rhumatol®
Arthritis Symptom and Muscle Pain Relief
To temporarily relieve symptoms commonly associated with arthritis and muscle pain, such as:
• pain
• inflammation
• stiffness
• swelling
2 fl oz (59 mL)
Homeopathic (OTC) Medicine
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 49726-004-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-23e5-f424-e053-dadaa90a57ce | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49726-004-02 | RhumatolArthitis Symptom and Muscle Pain Relief | 1 in 1 CARTON | LIQUID | 1 | 6 | |
| 49726-004-02 | RhumatolArthitis Symptom and Muscle Pain Relief | 59 mL in 1 BOTTLE, DROPPER | LIQUID | 59 | 6 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 49726-004 | RHUMATOL ARTHITIS SYMPTOM AND MUSCLE PAIN RELIEF (ACTAEA SPICATA, AESCULUS HIPPOCASTANUM, ARNICA MONTANA, BELLIS PERENNIS, BRYONIA, CALCAREA CARBONICA, CALCAREA FLUORICA, CAUSTICUM, CIMICIFUGA RACEMOSA, FORMICUM ACIDUM, HYPERICUM PERFORATUM, LEDUM PAULSTRE, LITHIUM CARBONICUM, MAGNESIA PHOSPHORICA, PHOSPHORUS, PHYTOLACCA DECANDRA, PULSATILLA, RHODODENDRON CHRYSANTHUM, RHUS TOXICODENDRON, RUTA GRAVEOLENS, SALICYLICUM ACIDUM, SEPIA, ZINCUM METALLICUM) LIQUID [HELLO LIFE, INC.] | 6 | Legacy NDC, 2 package rows | 20181227_14388c93-bb9f-48f6-a743-f36c6f7e4976.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ACTAEA SPICATA ROOT | ACTIVE INGREDIENT | 3FU86L9OS0 | 5 | |
| ARNICA MONTANA | ACTIVE INGREDIENT | O80TY208ZW | 5 | |
| BELLIS PERENNIS | ACTIVE INGREDIENT | 2HU33I03UY | 5 | |
| BLACK COHOSH | ACTIVE INGREDIENT | K73E24S6X9 | 5 | |
| BRYONIA ALBA ROOT | ACTIVE INGREDIENT | T7J046YI2B | 5 | |
| CALCIUM FLUORIDE | ACTIVE INGREDIENT | O3B55K4YKI | 5 | |
| CAUSTICUM | ACTIVE INGREDIENT | DD5FO1WKFU | 5 | |
| FORMIC ACID | ACTIVE INGREDIENT | 0YIW783RG1 | 5 | |
| HORSE CHESTNUT | ACTIVE INGREDIENT | 3C18L6RJAZ | 5 | |
| HYPERICUM PERFORATUM | ACTIVE INGREDIENT | XK4IUX8MNB | 5 | |
| LEDUM PALUSTRE TWIG | ACTIVE INGREDIENT | 877L01IZ0P | 5 | |
| LITHIUM CARBONATE | ACTIVE INGREDIENT | 2BMD2GNA4V | 5 | |
| MAGNESIUM PHOSPHATE, TRIBASIC, PENTAHYDRATE | ACTIVE INGREDIENT | 453COF7817 | 5 | |
| OYSTER SHELL CALCIUM CARBONATE, CRUDE | ACTIVE INGREDIENT | 2E32821G6I | 5 | |
| PHOSPHORUS | ACTIVE INGREDIENT | 27YLU75U4W | 5 | |
| PHYTOLACCA AMERICANA ROOT | ACTIVE INGREDIENT | 11E6VI8VEG | 5 | |
| PULSATILLA VULGARIS | ACTIVE INGREDIENT | I76KB35JEV | 5 | |
| RHODODENDRON AUREUM LEAF | ACTIVE INGREDIENT | IV92NQJ73U | 5 | |
| RUTA GRAVEOLENS FLOWERING TOP | ACTIVE INGREDIENT | N94C2U587S | 5 | |
| SALICYLIC ACID | ACTIVE INGREDIENT | O414PZ4LPZ | 5 | |
| SEPIA OFFICINALIS JUICE | ACTIVE INGREDIENT | QDL83WN8C2 | 5 | |
| TOXICODENDRON PUBESCENS LEAF | ACTIVE INGREDIENT | 6IO182RP7A | 5 | |
| ZINC | ACTIVE INGREDIENT | J41CSQ7QDS | 5 | |
| ACTAEA SPICATA ROOT | ACTIVE MOIETY | 3FU86L9OS0 | 5 | |
| ARNICA MONTANA | ACTIVE MOIETY | O80TY208ZW | 5 | |
| BELLIS PERENNIS | ACTIVE MOIETY | 2HU33I03UY | 5 | |
| BLACK COHOSH | ACTIVE MOIETY | K73E24S6X9 | 5 | |
| BRYONIA ALBA ROOT | ACTIVE MOIETY | T7J046YI2B | 5 | |
| CAUSTICUM | ACTIVE MOIETY | DD5FO1WKFU | 5 | |
| FLUORIDE ION | ACTIVE MOIETY | Q80VPU408O | 5 | |
| FORMIC ACID | ACTIVE MOIETY | 0YIW783RG1 | 5 | |
| HORSE CHESTNUT | ACTIVE MOIETY | 3C18L6RJAZ | 5 | |
| HYPERICUM PERFORATUM | ACTIVE MOIETY | XK4IUX8MNB | 5 | |
| LEDUM PALUSTRE TWIG | ACTIVE MOIETY | 877L01IZ0P | 5 | |
| LITHIUM CATION | ACTIVE MOIETY | 8H8Z5UER66 | 5 | |
| MAGNESIUM CATION | ACTIVE MOIETY | T6V3LHY838 | 5 | |
| OYSTER SHELL CALCIUM CARBONATE, CRUDE | ACTIVE MOIETY | 2E32821G6I | 5 | |
| PHOSPHORUS | ACTIVE MOIETY | 27YLU75U4W | 5 | |
| PHYTOLACCA AMERICANA ROOT | ACTIVE MOIETY | 11E6VI8VEG | 5 | |
| PULSATILLA VULGARIS | ACTIVE MOIETY | I76KB35JEV | 5 | |
| RHODODENDRON AUREUM LEAF | ACTIVE MOIETY | IV92NQJ73U | 5 | |
| RUTA GRAVEOLENS FLOWERING TOP | ACTIVE MOIETY | N94C2U587S | 5 | |
| SALICYLIC ACID | ACTIVE MOIETY | O414PZ4LPZ | 5 | |
| SEPIA OFFICINALIS JUICE | ACTIVE MOIETY | QDL83WN8C2 | 5 | |
| TOXICODENDRON PUBESCENS LEAF | ACTIVE MOIETY | 6IO182RP7A | 5 | |
| ZINC | ACTIVE MOIETY | J41CSQ7QDS | 5 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 5 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 5 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 5 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 49726-004 | 49726-004-02 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | DOUCHE / VAGINAL | 0.07 %w/w | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | LOTION / TOPICAL | 0.2 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / TOPICAL | 0.01 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / VAGINAL | 0.49 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, CHEWABLE / ORAL | 7 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LOTION / TOPICAL | 0.85 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INFILTRATION | 0.02 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAMUSCULAR | 28 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY, METERED / NASAL | 2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / IONTOPHORESIS | 0.02 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRACARDIAC | 1.05 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / RESPIRATORY (INHALATION) | 0.13 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRATHECAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / PERIDURAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRALESIONAL | ADJ PH | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SPRAY, METERED / NASAL | 0.06 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET / ORAL | 6 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | OINTMENT / TOPICAL | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY / NASAL | 9 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAMUSCULAR | 26 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CAPSULE / ORAL | 238 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EXTENDED RELEASE / ORAL | 45 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / NASAL | 2.8 mg/1ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYSTEM / TOPICAL | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER / ORAL | 840 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, FILM COATED / ORAL | 42 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SUSPENSION / ORAL | 400 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / ORAL | 269 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / OPHTHALMIC | 0.03 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EFFERVESCENT / ORAL | 460 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | GEL / TOPICAL | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / TOPICAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / TOPICAL | 4 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / ORAL | 446 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SHAMPOO / TOPICAL | 17 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAVENOUS | 10 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRABURSAL | ADJ PH | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / EPIDURAL | 0.02 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 608 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 385 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING / ORAL | 83 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYSTEM / IONTOPHORESIS | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | FILM, EXTENDED RELEASE / TRANSDERMAL | 1.38 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION/ DROPS / ORAL | 19 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / OPHTHALMIC | ADJ PH | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | AEROSOL, FOAM / TOPICAL | 8 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | FILM / SUBLINGUAL | 10 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION/ DROPS / OPHTHALMIC | 0.47 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / TOPICAL | 17 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION, CONCENTRATE / IRRIGATION | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRA-ARTICULAR | ADJ PH | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION / RECTAL | 6.67 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | ELIXIR / ORAL | 100 mg/5ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / BUCCAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYRUP / ORAL | 722 mg/5ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CAPSULE, EXTENDED RELEASE / ORAL | 101 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 7df08284-236b-0914-e053-2991aa0aa0fa | 14388c93-bb9f-48f6-a743-f36c6f7e4976 | 2018-12-26 | Warnings | 7df08284-236b-0914-e053-2991aa0aa0fa 14388c93-bb9f-48f6-a743-f36c6f7e4976 |
Adverse event summaries are temporarily unavailable. Other product information remains available.